Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

461 projects found matching your search criteria :

  1. Combination therapy with naphthoquinones and paclitaxel in the pharmacological induction of cell death in breast cancer ...

    Call: OPUS 2 , Panel: NZ7

    Principal investigator: dr Anna Kawiak

    Uniwersytet Gdański

  2. Regulation of ALKBH proteins expression in cancer and its role in cancer therapy.

    Call: OPUS 2 , Panel: NZ4

    Principal investigator: prof. Elżbieta Grzesiuk

    Instytut Biochemii i Biofizyki PAN

  3. Pathogenesis of ovarian cancer survival in non-adhesion conditions: transcriptomic assessment and studies of molecular t...

    Call: PRELUDIUM 2 , Panel: NZ1

    Principal investigator: dr Anna Stachurska

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie

  4. Combined induction of cell death of canine leukemia and lymphoma.

    Call: OPUS 2 , Panel: NZ5

    Principal investigator: dr hab. Andrzej Marek Rapak

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  5. Activity evaluation of procaryotic TA modules in a dual-component model of cancer therapy

    Call: PRELUDIUM 2 , Panel: NZ5

    Principal investigator: Łukasz Janusz Wieteska

    Uniwersytet Medyczny w Łodzi, Wydział Nauk o Zdrowiu; Zakład Biochemii Medycznej

  6. Next-Generation Exosome Therapy: Engineering NK Cell-Derived Vesicles for Targeted Cancer Treatment

    Call: SONATINA 9 , Panel: NZ6

    Principal investigator: dr Daria Nawrocka

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  7. The role of DNA methylation in therapy that increases CFTR channel activity in cystic fibrosis

    Call: SONATA 20 , Panel: NZ5

    Principal investigator: dr Beata Maria Narożna

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  8. The role of structural changes of lung surfactants in pulmonary diseases – from physicochemical description to effective...

    Call: OPUS 28 , Panel: ST4

    Principal investigator: dr hab. Dorota Matyszewska

    Uniwersytet Warszawski

  9. Mind the gap! Plasmonic nanocavity for spectroscopic trapping of local molecularrearrangements in DNA upon epigenetic mo...

    Call: OPUS 28 , Panel: ST4

    Principal investigator: prof. Ewelina Wioletta Lipiec

    Uniwersytet Jagielloński

  10. The role of EZH2 activity in the development of resistance to targeted therapy in melanoma

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr Michał Jerzy Woźniak

    Uniwersytet Medyczny w Łodzi

  11. Janus nanoparticles - research on the effect of the duality of carriers of the activesubstance in targeted therapy of sk...

    Call: OPUS 28 , Panel: ST8

    Principal investigator: dr hab. Bożena Anna Tyliszczak

    Politechnika Krakowska im. Tadeusza Kościuszki

  12. The influence of beta2-receptor N-terminal polymorphismsadrenergic on its functionality, interactions withdrugs and the ...

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr hab. Anita Elżbieta Płazińska

    Uniwersytet Medyczny w Lublinie

  13. Prolonged-release of selected antiangiogenic proteins from innovative nanocarrier for use in adjuvant/additive multiple ...

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: prof. Bogusław Bronisław Machaliński

    Pomorski Uniwersytet Medyczny w Szczecinie

  14. Cannabidiol as a Neuroprotective Therapy: Are Brain Regeneration Mechanisms After Perinatal Hypoxia-Ischemia Sex-Depende...

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Hanna Kletkiewicz

    Uniwersytet Mikołaja Kopernika

  15. Combating Hypoxia to prevent Right Ventricular Failure in experimental pulmonary hypertension - role of energetics, fibr...

    Call: OPUS 28 , Panel: NZ4

    Principal investigator: dr hab. Michał Maria Mączewski

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

  16. Ir(III), Re(I) and Heterobimetallic Ir(III)–Re(I) Systems as Effective Emitters and Photosensitizers

    Call: SONATA 20 , Panel: ST4

    Principal investigator: dr Katarzyna Anna Choroba

    UNIWERSYTET ŚLĄSKI

  17. Investigation of the mechanism of enhanced liposome delivery to tumors and its application for dual target immunotherapy

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr hab. Tomasz Piotr Rygiel

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  18. Environmental modulation of CDK4/6 inhibitor efficacy: Impact of mycotoxin alternariol exposure on anti-cancer therapies

    Call: SONATA 20 , Panel: NZ5

    Principal investigator: dr Anna Dominika Walczak-Szeffer

    Uniwersytet Medyczny w Łodzi

  19. Light Against Darkness: Biocompatible Photoactivated Pharmaceuticals for Combating Multidrug Resistant Bacterial Infecti...

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr hab. Janusz Marcin Dąbrowski

    Uniwersytet Jagielloński

  20. Neutrophil Dynamics: Unveiling Anti-Tumor and Therapy Efficacy with the TUmor Neutrophil Immunotherapy on Chip (TUNIC) m...

    Call: SONATA 20 , Panel: NZ6

    Principal investigator: dr Martin Nurmik

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

  21. Biomimetic scaffolds modified with ferulic acid dedicated to necrotic wound therapy

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Beata Kaczmarek-Szczepańska

    Uniwersytet Mikołaja Kopernika

  22. Prevalence of viral genomes, histological, and immunohistochemical features of myocarditis in the myocardium, and freque...

    Call: SONATA 20 , Panel: NZ6

    Principal investigator: dr hab. Krzysztof Ozierański

    Warszawski Uniwersytet Medyczny

  23. Where Inhibition is not Enough- Development of Innovative Compounds for Targeted Degradation of Extracellular and Membra...

    Call: OPUS 28 (LAP) , Panel: NZ5

    Principal investigator: dr Marcin Skoreński

    Politechnika Wrocławska

  24. "Integrated Fixed-Dose Combination Drugs in Depression Therapy: A New Standard of Treatment and Mechanism of Action Stud...

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: prof. Gabriel Piotr Nowak

    Instytut Farmakologii PAN

  25. Application of bioconjugation strategy to the synthesis of anticancer Trojan horses

    Call: OPUS 28 , Panel: ST5

    Principal investigator: dr hab. Michał Piotr Antoszczak

    Uniwersytet im. Adama Mickiewicza w Poznaniu

  26. Computational and experimental nanodosimetry for proton radiotherapy

    Call: WEAVE-UNISONO , Panel: ST2

    Principal investigator: dr hab. Antoni Wojciech Ruciński

    Instytut Fizyki Jądrowej im. Henryka Niewodniczańskiego PAN

  27. The first antibody-drug conjugates for Alzheimer's disease therapy

    Call: SONATA BIS 14 , Panel: NZ5

    Principal investigator: dr hab. Marcin Łukasz Poręba

    Politechnika Wrocławska

  28. Quad-TNT: Quadruplex-Targeted Photo-Therapy for Triple-Negative Tumors

    Call: SONATA BIS 14 , Panel: NZ5

    Principal investigator: dr Marco Deiana

    Politechnika Wrocławska

  29. M6A RNA methylation signatures as a targets for HPV-dependent HNSCC therapy

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: Kamila Ostrowska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  30. Phage Therapy Antipersister Strategy

    Call: JPIAMR ACTION Call 2024 , Panel: NZ6

    Principal investigator: prof. Zuzanna Drulis-Kawa

    Uniwersytet Wrocławski

  31. Phage-Antimicrobial combination Strategies for management of multidrug-resistant E. coli and K. pneumoniae

    Call: JPIAMR ACTION Call 2024 , Panel: NZ7

    Principal investigator: prof. Krystyna Dąbrowska

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  32. Genetic background of chromothripsis, its role in clonal evolution and response to therapy in childhood acute lymphoblas...

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: dr hab. Agata Karolina Pastorczak

    Uniwersytet Medyczny w Łodzi

  33. Potential application of selected antimicrobial peptides in the anti-staphylococcal therapy in cystic fibrosis patients.

    Call: OPUS 2 , Panel: NZ5

    Principal investigator: dr hab. Katarzyna Maria Garbacz

    Gdański Uniwersytet Medyczny, Wydział Lekarski

  34. Impact of sodium chloride supplementation for natriuresis, blood pressure and neurohormonal activity in Chronic Heart Fa...

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Mateusz Guzik

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

  35. The use of photosensitizers to improve the efficiency of radiotherapy

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: dr Justyna Anna Czapla

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie

  36. Assessment of long-term effects of semaglutide administered in repeated short cycles in obese mice

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: dr hab. Jakub Łukasz Wojcieszak

    Uniwersytet Medyczny w Łodzi

  37. Synthesis of novel hybrid nanomaterials based on fullerene scaffold for photodynamic therapy of cancer

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Dominik Jakub Dreszer

    UNIWERSYTET ŚLĄSKI

  38. Assessment of the potential of new histidine hybrids and simulation of their metabolism as a potential therapy for neuro...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: prof. Paweł Bartosz Szymański

    Uniwersytet Medyczny w Łodzi

  39. Assessment of virulence, biofilm formation and drug-susceptibility of Candida albicans treated with plant essential oils...

    Call: PRELUDIUM 1 , Panel: NZ6

    Principal investigator: Aleksandra Budzyńska

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  40. Identification and characterization of omics profiles in patients' serum during anti-CD19 CAR-T cell therapy

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Jaromir Bartosz Tomasik

    Warszawski Uniwersytet Medyczny

  41. REMIND HF - Evaluation of REmote Motivational INterviewing for Disease management in Heart Failure patients and their ca...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: prof. Izabella Uchmanowicz

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

  42. Radiolabelled up-converting nanoparticles as theranostic agents for multimodal imaging and targeted therapy

    Call: SONATINA 8 , Panel: ST5

    Principal investigator: dr Karolina Kinga Zajdel

    Narodowe Centrum Badań Jądrowych

  43. Miniature CRISPR/Cas nucleases for upregulation of utrophin expression: a novel approach for mutation-independent therap...

    Call: DAINA 3 , Panel: NZ3

    Principal investigator: prof. Józef Dulak

    Uniwersytet Jagielloński

  44. Nature-inspired conductive and bioadhesive kirigami-based nanoarchitectured cardiac patch for combined chemo- and stem c...

    Call: OPUS 26 , Panel: ST5

    Principal investigator: dr hab. Filippo Pierini

    Instytut Podstawowych Problemów Techniki Polska Akademia Nauk

  45. Potential pharmacological strategies aimed at alleviating cognitive dysfunctions accompanying oncological therapy while ...

    Call: OPUS 26 , Panel: NZ5

    Principal investigator: dr hab. Joanna Monika Wierońska

    Instytut Farmakologii PAN

  46. LighTEM - light-induced in situ electron microscopy and its application in the imaging of light-matter interactions on t...

    Call: SONATA 19 , Panel: ST11

    Principal investigator: dr hab. Andrzej Marek Żak

    Politechnika Wrocławska

  47. Organometallic marriage of sugars with porphyrins. Towards new photosensitizers.

    Call: SONATA 19 , Panel: ST5

    Principal investigator: dr Maciej Malinowski

    Politechnika Warszawska, Wydział Chemiczny

  48. Synthesis, characterization, and evaluation of the biological activity of innovative thermosensitive suppositories compr...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Ewa Olędzka

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

  49. The optimal rate of cooling and protection against brain hyperferremia - as a potential therapy of neonatal asphyxia

    Call: OPUS 2 , Panel: NZ7

    Principal investigator: dr hab. Justyna Żaneta Rogalska

    Uniwersytet Mikołaja Kopernika, Wydział Biologii i Ochrony Środowiska

  50. First-in-class dual modulators of necroptosis kinases and 5-HT6 receptors as an innovative approach to develop an effect...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: prof. Jadwiga Handzlik

    Uniwersytet Jagielloński, Collegium Medicum

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy